On Drugs: Preemption, Presumption, and Remedy

Document Type

Article

Publication Date

5-2018

ISSN

0194-7648

Publisher

Taylor & Francis

Language

en-US

Abstract

This essay explores the role of litigation in drug safety regulation and the role of drug safety regulation in litigation, exemplified by the 2017 National Health Law Moot Court Problem. Using the example of failure-to-update claims against generic drug manufacturers, this essay argues that pharmaceutical preemption doctrine would benefit from a tailored application of the presumption against preemption. It proposes a presumption that Congress does not intend to displace historic state remedies for injury without clearly saying so, focusing on the role of remedy to account for the evolving overlap in federal and state police powers over health and to more precisely calibrate the federalism values inherent in the remedy-regulation relationship.

Additional Files
On Drugs_ Preemption, Presumption, and Remedy_Pre-print Author’s Original Manuscript.pdf (283 kB)
Pre-print Author’s Original Manuscript

This document is currently not available here.

Find on SSRN

Please note the file available on SSRN may not be the final published version of this work. 

Link to Publisher Site (BU Community Subscription)

Share

COinS